Similar articles for PMID: 29491116

Year	Number of Results
1989	1
1992	1
1995	2
1996	1
1998	1
1999	1
2003	1
2004	3
2005	4
2006	2
2007	5
2008	7
2009	1
2010	4
2011	5
2012	5
2013	8
2014	3
2015	7
2016	11
2017	22
2018	14
2019	14
2020	9
2021	3
2022	5
2023	3

1

Tumor Hypoxia Detected by ¹⁸F-fluoromisonidazole Positron Emission Tomography (FMISO PET) as a Prognostic Indicator of Radiotherapy (RT).

Tachibana I, Nishimura Y, Hanaoka K, Inada M, Fukuda K, Tatebe H, Ishikawa K, Nakamatsu K, Kanamori S, Hosono M. Tachibana I, et al. Anticancer Res. 2018 Mar;38(3):1775-1781. doi: 10.21873/anticanres.12415. Anticancer Res. 2018. PMID: 29491116

2

The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.

Okamoto S, Shiga T, Yasuda K, Watanabe S, Hirata K, Nishijima KI, Magota K, Kasai K, Onimaru R, Tuchiya K, Kuge Y, Shirato H, Tamaki N. Okamoto S, et al. Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2147-2154. doi: 10.1007/s00259-016-3431-4. Epub 2016 Jun 1. Eur J Nucl Med Mol Imaging. 2016. PMID: 27251644 Clinical Trial.

3

Comparison of Hypermetabolic and Hypoxic Volumes Delineated on [¹⁸F]FDG and [¹⁸F]Fluoromisonidazole PET/CT in Non-small-cell Lung Cancer Patients.

Thureau S, Modzelewski R, Bohn P, Hapdey S, Gouel P, Dubray B, Vera P. Thureau S, et al. Mol Imaging Biol. 2020 Jun;22(3):764-771. doi: 10.1007/s11307-019-01422-6. Mol Imaging Biol. 2020. PMID: 31432388

4

Hypoxic volume evaluated by ¹⁸F-fluoromisonidazole positron emission tomography (FMISO-PET) may be a prognostic factor in patients with oral squamous cell carcinoma: preliminary analyses.

Sato J, Kitagawa Y, Watanabe S, Asaka T, Ohga N, Hirata K, Shiga T, Satoh A, Tamaki N. Sato J, et al. Int J Oral Maxillofac Surg. 2018 May;47(5):553-560. doi: 10.1016/j.ijom.2017.09.007. Epub 2017 Oct 10. Int J Oral Maxillofac Surg. 2018. PMID: 29030021

5

Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.

Wang H, Zhang Y, Yu W, Zhao X, Xue Y, Xu H. Wang H, et al. Nucl Med Commun. 2016 Jul;37(7):705-14. doi: 10.1097/MNM.0000000000000498. Nucl Med Commun. 2016. PMID: 26963468

6

A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.

Tachibana I, Nishimura Y, Shibata T, Kanamori S, Nakamatsu K, Koike R, Nishikawa T, Ishikawa K, Tamura M, Hosono M. Tachibana I, et al. J Radiat Res. 2013 Nov 1;54(6):1078-84. doi: 10.1093/jrr/rrt033. Epub 2013 Apr 14. J Radiat Res. 2013. PMID: 23589026 Free PMC article. Clinical Trial.

7

18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.

Kikuchi M, Yamane T, Shinohara S, Fujiwara K, Hori SY, Tona Y, Yamazaki H, Naito Y, Senda M. Kikuchi M, et al. Ann Nucl Med. 2011 Nov;25(9):625-33. doi: 10.1007/s12149-011-0508-9. Epub 2011 Jul 1. Ann Nucl Med. 2011. PMID: 21720778

8

¹⁸F-HX4/¹⁸F-FMISO-based micro PET for imaging of tumor hypoxia and radiotherapy-associated changes in mice.

Yu W, Qiao F, Su X, Zhang D, Wang H, Jiang J, Xu H. Yu W, et al. Biomed Pharmacother. 2019 Nov;119:109454. doi: 10.1016/j.biopha.2019.109454. Epub 2019 Sep 14. Biomed Pharmacother. 2019. PMID: 31526971 Free article.

9

High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.

Okamoto S, Shiga T, Yasuda K, Ito YM, Magota K, Kasai K, Kuge Y, Shirato H, Tamaki N. Okamoto S, et al. J Nucl Med. 2013 Feb;54(2):201-7. doi: 10.2967/jnumed.112.109330. Epub 2013 Jan 15. J Nucl Med. 2013. PMID: 23321456 Free article.

10

To Explore a Representative Hypoxic Parameter to Predict the Treatment Response and Prognosis Obtained by [¹⁸F]FMISO-PET in Patients with Non-small Cell Lung Cancer.

Li L, Wei Y, Huang Y, Yu Q, Liu W, Zhao S, Zheng J, Lu H, Yu J, Yuan S. Li L, et al. Mol Imaging Biol. 2018 Dec;20(6):1061-1067. doi: 10.1007/s11307-018-1190-2. Mol Imaging Biol. 2018. PMID: 29623510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

126 results

Results by year